Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management.

M Ellis1, M Richardson

  • 1Faculty of Medicine and Health Sciencs, United Arab Emirates University.

Hospital Medicine (London, England : 1998)
|October 26, 2000
PubMed
Summary
This summary is machine-generated.

Managing invasive fungal infections requires a multidisciplinary approach including antifungals and surgery. Newer treatments are emerging due to evolving pathogens and the need for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper restriction unmasks axonal degeneration in a mouse model of X-linked hereditary motor neuropathy.

Metallomics : integrated biometal science·2026
Same author

The potential for carbon dioxide removal by enhanced rock weathering in the tropics: An evaluation of Costa Rica.

The Science of the total environment·2024
Same author

A Compound Heterozygous Mutation in <i>Calpain 1</i> Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4).

Frontiers in genetics·2022
Same author

"Always Events® "… just another quality improvement tool … or is it?

Radiography (London, England : 1995)·2020
Same author

Review: Effects of Ractopamine Hydrochloride (Paylean) on welfare indicators for market weight pigs.

Translational animal science·2020
Same author

Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation.

Scientific reports·2020
Same journal

Management of non-thrombolysable acute coronary syndrome (ACS).

Hospital medicine (London, England : 1998)·2005
Same journal

Case report: treatment of faecaloma of the colon.

Hospital medicine (London, England : 1998)·2005
Same journal

Should anaesthetists scrub? The case for and against.

Hospital medicine (London, England : 1998)·2005
Same journal

Angiosarcoma: a difficult diagnosis.

Hospital medicine (London, England : 1998)·2005
Same journal

Pitfalls in recurrent varicose vein surgery.

Hospital medicine (London, England : 1998)·2005
Same journal

Aorto-caval fistula.

Hospital medicine (London, England : 1998)·2005
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections (IFIs) necessitate a multidisciplinary management strategy.
  • Treatment traditionally relies on antifungals, surgery, and immuno-correction.
  • Conventional amphotericin B has been a primary therapeutic agent.

Purpose of the Study:

  • To review the evolving landscape of invasive fungal infection management.
  • To highlight the development of novel antifungal agents and formulations.
  • To address challenges posed by emerging fungal pathogens and suboptimal treatment outcomes.

Main Methods:

  • Literature review of antifungal therapies.
  • Analysis of treatment strategies for invasive fungal infections.

Related Experiment Videos

  • Examination of new antifungal drug development and formulations.

    • Main Results:

    • Conventional amphotericin B remains a cornerstone but faces limitations.
    • Emerging fungal pathogens necessitate updated treatment protocols.
    • Novel antifungal formulations and agents show promise in improving outcomes.

    Conclusions:

    • Multidisciplinary management is crucial for invasive fungal infections.
    • Advancements in antifungal drug development are critical for combating resistant pathogens.
    • Continued research into novel therapies is essential for improving patient survival rates.